94 related articles for article (PubMed ID: 7334719)
1. [Cell-mediated immunity and effects of cyclophosphamide on primary nephrotic syndrome (author's transl)].
Okura T; Matsuo S; Kumon S; Hibi I; Tamaki S; Watanabe Y; Kinoshita Y
Nihon Jinzo Gakkai Shi; 1981 Nov; 23(11):1395-403. PubMed ID: 7334719
[No Abstract] [Full Text] [Related]
2. [The cyclophosphamide treatment of glomerulonephritis patients].
Dorets'kyĭ VV
Vrach Delo; 1991 Feb; (2):51-3. PubMed ID: 2058123
[TBL] [Abstract][Full Text] [Related]
3. [Long-term effects of cyclophosphamide therapy in treatment of the "primary" nephrotic syndrome of childhood].
Lama G
Pediatria (Napoli); 1976 Jun; 84(2):320-30. PubMed ID: 798171
[No Abstract] [Full Text] [Related]
4. [Cell mediated immunity in a mercury nephrotic syndrome (author's transl)].
Normand M; Cayotte JL; Chouraqui D; Fizet D
Sem Hop; 1982 May; 58(19):1185-7. PubMed ID: 6285502
[TBL] [Abstract][Full Text] [Related]
5. [Immune abnormality in primary nephrotic syndrome--a study of cell mediated immunity with special reference to suppressor cell (author's transl)].
Hibi I; Okura T; Kumon S; Matsuo S; Tamaki S; Sakamoto N
Nihon Jinzo Gakkai Shi; 1981 Aug; 23(8):1067-86. PubMed ID: 6459475
[No Abstract] [Full Text] [Related]
6. [Immunosuppressors and immunostimulants in the treatment of chronic glomerulonephritis patients with the nephrotic syndrome].
Nazar PS
Vrach Delo; 1987 Mar; (3):86-9. PubMed ID: 3590711
[No Abstract] [Full Text] [Related]
7. [Use of cyclophosphamide in membranoproliferative glomerulonephritis].
Wills H; Villarreal H
Arch Inst Cardiol Mex; 1976; 46(6):770-5. PubMed ID: 1023835
[TBL] [Abstract][Full Text] [Related]
8. [Idiopathic nephrotic syndrome in children (author's transl)].
Cornu G; Gosseye S; Kumps N
Acta Paediatr Belg; 1973; 27(5):305-28. PubMed ID: 4779692
[No Abstract] [Full Text] [Related]
9. [Serum immunoglobulin level in children with nephrotic syndrome treated with cyclophosphamide].
Fydryk J
Pediatr Pol; 1974 Jun; 49(6):679-85. PubMed ID: 4839775
[No Abstract] [Full Text] [Related]
10. [Use of cyclophosphamide and corticoids in the treatment of nephrotic syndrome: controlled study].
Rocha H; Vaccaro Torres CE; Lessa I; Azevêdo Vinhaes L
Rev Bras Pesqui Med Biol; 1972; 5(1-2):21-8. PubMed ID: 4680451
[No Abstract] [Full Text] [Related]
11. [Treatment of nephrotic syndrome in children (author's transl)].
Schärer K
Monatsschr Kinderheilkd; 1980 Nov; 128(11):685-8. PubMed ID: 6110172
[TBL] [Abstract][Full Text] [Related]
12. [Ifosfamide in the treatment of nephrotic syndrome (author's transl)].
Gekle D; Daigeler C
Klin Padiatr; 1977 Sep; 189(5):370-5. PubMed ID: 562447
[TBL] [Abstract][Full Text] [Related]
13. [Effect of cyclophosphamide on the reproductive function -- study of testicular histology in male patients with nephrotic syndrome (author's transl)].
Ogata H; Shibata T; Hirai Y; Aratani H; Yokoyama K; Shinzato K; Taura K; Harada T; Fujimatsu S; Horita S; Hara K; Shindo K; Matsuo T; Nakayama I
Nihon Jinzo Gakkai Shi; 1981 Feb; 23(2):213-21. PubMed ID: 7253320
[No Abstract] [Full Text] [Related]
14. Cyclophosphamide therapy in the management of nephrotic syndrome.
Srivastava RN; Mayekar G; Anand R; Choudhry VP; Ghai OP
Indian Pediatr; 1974 Dec; 11(12):767-74. PubMed ID: 4448539
[No Abstract] [Full Text] [Related]
15. Treatment of nephrotic syndrome.
Gulati S; Kher V; Elhence R; Kumar P; Sharma RK; Gupta A
Indian Pediatr; 1994 Feb; 31(2):165-70. PubMed ID: 7875840
[TBL] [Abstract][Full Text] [Related]
16. Remission induced by chlorambucil in steroid-responsive, frequently relapsing nephrotic syndrome that relapsed after cyclophosphamide.
Bailey RR
N Z Med J; 1989 Jul; 102(872):379-81. PubMed ID: 2797556
[TBL] [Abstract][Full Text] [Related]
17. [Chronic myelogenous leukaemia as a possible consequence of immunosuppressive treatment of nephrotic syndrome (author's transl)].
Cáp J; Misíková Z
Monatsschr Kinderheilkd (1902); 1975 Oct; 123(10):718-20. PubMed ID: 1058334
[TBL] [Abstract][Full Text] [Related]
18. A clinicopathological study of nephrotic syndrome and role of immunosuppressive therapy.
Prasad R; Dayal RS; Srivastava VK; Bhatnagar AK; Jain S; Kapur S
Indian Pediatr; 1980 Dec; 17(12):923-9. PubMed ID: 7251119
[No Abstract] [Full Text] [Related]
19. Cell-mediated immunity in nephrotic syndrome.
Mallick NP; Williams RJ; McFarlane H; Orr WM; Taylor G; Williams G
Lancet; 1972 Mar; 1(7749):507-9. PubMed ID: 4110020
[No Abstract] [Full Text] [Related]
20. [Results of cyclophosphamide treatment of primary nephrotic syndrome in children].
Starkiewiczowa J; Fydryk J; Lupa B
Pediatr Pol; 1975 Jan; 50(1):31-6. PubMed ID: 1110844
[No Abstract] [Full Text] [Related]
[Next] [New Search]
